Illumina's competitors

Illumina's competitors include Synthetic Genomics, Perlara, Lexicon Pharmaceuticals and Sarepta Therapeutics
Add company...
Illumina
Illumina is a global company that develops innovative array-based solutions for DNA, RNA, and protein analysis.
Synthetic Genomics
Synthetic Genomics is a synthetic biology company that develops and commercializes genomic-driven technologies for various industries.
Perlara
Perlara, PBC is a biotech startup and Public Benefit Corporation based in the Bay Area that is on a mission to discover personalized cures for diseases rare and common.
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.
Sarepta Therapeutics
Sarepta Therapeutics is a biopharmaceutical company focused on developing innovative RNA-targeted therapeutics.
Founding Date
Founding Date
1998
Founding Date
2005
Founding Date
2013
Founding Date
1995
Founding Date
1980
Type
Type
Public
Type
Private
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
San Diego, US HQ
Scoresby, AU
São Paulo, BR
Victoria, CA
Shanghai, CN
Beijing, CN
Minato, JP
see more
Locations
La Jolla, US HQ
Locations
San Francisco, US HQ
Locations
Spring, US HQ
Jersey, JE
Indianapolis, US
The Woodlands, US
Boston, US
Chicago, US
Philadelphia, US
see more
Locations
Cambridge, US HQ
Employees
Employees
6,200 13% increase
Employees
199 2% increase
Employees
3
Employees
168
Employees
197
Valuation ($)
Valuation ($)
33.9 b
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
829.9 m
Valuation ($)
3.9 b
Facebook followers
Facebook followers
15 k
Facebook followers
3.6 k
Facebook followers
389
Facebook followers
N/A
Facebook followers
N/A
Twitter followers
Twitter followers
54.4 k
Twitter followers
2.6 k
Twitter followers
2.9 k
Twitter followers
104
Twitter followers
197

Financial

Revenue (est.)
Revenue (est.)
$2.4b (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$83.3m (FY, 2016)
Revenue (est.)
$5.4m (FY, 2016)
Cost of goods
Cost of goods
$731.9m (FY, 2017)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$130k (FY, 2016)
Gross profit
Gross profit
$1.7b (FY, 2017)
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Gross profit
$5.3m (FY, 2016)
Net income
Net income
$428.1m (FY, 2017)
Net income
N/A
Net income
N/A
Net income
($141.4m) (FY, 2016)
Net income
($267.3m) (FY, 2016)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 10m (about 5 years ago)
Latest funding round
$ 120k (almost 2 years ago)
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
N/A
Total funding raised
$ 40m
Total funding raised
$ 7.3m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles